BioSpace News Archive

$18.5 million in extension funding will support clinical pipeline of microbiome-derived product candidates

Hansa Biopharma AB announced that the Company’s management team will participate in the following upcoming investor conferences:

First commercial sale triggers $20 million milestone payment to Exelixis

The lines between the physical and digital worlds are becoming increasingly blurred. Traditional markets are being redefined, customer expectations are constantly evolving, and the very way daily tasks are conducted are being rapidly transformed.

World’s highest field preclinical MRI will be used for oncology and neuroscience research

Titan Pharmaceuticals, Inc. announced that it has executed a product purchase and supply agreement with Accredo specialty pharmacy, a subsidiary of Express Scripts, further expanding access to treatment with Probuphine implant, Titan’s novel maintenance treatment for Opioid Use Disorder in eligible patients.

€62M funding will be used to progress wholly-owned pipeline products through clinical development and expand manufacturing activities Dr. Guido Guidi, Dr. Roberto Ferraresi and Dr. Roberto Marsella join the board of directors

4D pharma plc announces its participation in the Neuro4D conference, Frankfurt, Germany, 13-14 May, 2019.

The Permanente Federation announced that Katherine Robinson Saral will join the company as chief legal officer effective May 29, 2019.

The combination therapy, of two FDA approved drugs, protects the blood-brain-barrier and is aimed at preventing development of brain pathologies